The board of directors approved the distribution following powers granted during the April 24, 2025, Annual General Shareholders Meeting. The payment reflects the firm's current outstanding share count and aligns with its stated objective to maintain a consistent quarterly dividend schedule for investors. Genomma Lab, which trades under the ticker LABB, remains a significant player in the Latin American market for pharmaceutical and personal care products. The company’s financial strategy balances this dividend policy against broader market variables, including currency fluctuations and supply chain dynamics, as noted in its regulatory filings with the Bolsa Mexicana de Valores.
Genomma Lab Declares 200 Million Peso Dividend
Mexico City-based pharmaceutical firm Genomma Lab Internacional has filed a notice with the Mexican Stock Exchange, authorizing a cash dividend of 0.20 pesos per share. This payout, totaling 200 million pesos, marks the company's seventeenth dividend distribution as it continues to execute its strategy of quarterly shareholder returns.
Comments (0)
No comments yet. Be the first!